{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:49:54Z","timestamp":1789753794787,"version":"4.0.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Scholar of Fonds de Recherche du Qu\u00e9bec en Sant\u00e9"},{"name":"University of Montreal Scleroderma Research Chair"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03662-0","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:04:58Z","timestamp":1763024698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study"],"prefix":"10.1186","volume":"27","author":[{"given":"Hao Cheng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Bourr\u00e9-Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Zarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Nehme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Makhzoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Mereniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie-S\u00e9l\u00e8ne","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Bouchard-Marmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Poirier-Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred\u00e9ric","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Richard","family":"Goulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Raynauld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martial","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Allard-Chamard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Chartrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ivensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Infantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Betteridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Leclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Karamchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Hervier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"O\u2019Ferrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ellezam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira N.","family":"Targoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Sen\u00e9cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Troyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"12","key":"3662_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","volume":"19","author":"AGS Oldroyd","year":"2023","unstructured":"Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, et al. International guideline for idiopathic inflammatory myopathy-associated cancer screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat Rev Rheumatol. 2023;19(12):805\u201317.","journal-title":"Nat Rev Rheumatol"},{"issue":"14","key":"3662_CR2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa2117912","volume":"387","author":"R Aggarwal","year":"2022","unstructured":"Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csorgo Z, Dimachkie MM, Griger Z, et al. Trial of intravenous immune globulin in dermatomyositis. N Engl J Med. 2022;387(14):1264\u201378.","journal-title":"N Engl J Med"},{"issue":"12","key":"3662_CR3","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3662_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/ard-2023-223873","volume":"82","author":"I Pinal-Fernandez","year":"2023","unstructured":"Pinal-Fernandez I, Milisenda JC, Pak K, Munoz-Braceras S, Casal-Dominguez M, Torres-Ruiz J, et al. Transcriptional derepression of CHD4\/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies. Ann Rheum Dis. 2023;82(8):1091\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3662_CR5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/ard-2024-225773","volume":"83","author":"I Pinal-Fernandez","year":"2024","unstructured":"Pinal-Fernandez I, Munoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J, et al. Pathological autoantibody internalisation in myositis. Ann Rheum Dis. 2024;83(11):1549\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3662_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/art.41964","volume":"74","author":"M Casal-Dominguez","year":"2022","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Pak K, Huang W, Selva-O\u2019Callaghan A, Albayda J, et al. Performance of the 2017 European Alliance of Associations for Rheumatology\/American College of Rheumatology classification criteria for idiopathic inflammatory myopathies in patients with myositis-specific autoantibodies. Arthritis Rheumatol. 2022;74(3):508\u201317.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"3662_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005;84(4):231\u201349.","journal-title":"Medicine (Baltimore)"},{"issue":"24","key":"3662_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/MD.0000000000000222","volume":"93","author":"Y Troyanov","year":"2014","unstructured":"Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, et al. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore). 2014;93(24):318\u201332.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"3662_CR9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/art.40063","volume":"69","author":"JL Senecal","year":"2017","unstructured":"Senecal JL, Raynauld JP, Troyanov Y. Editorial: a new classification of adult autoimmune myositis. Arthritis Rheumatol. 2017;69(5):878\u201384.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"3662_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","volume":"54","author":"P Gerami","year":"2006","unstructured":"Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol. 2006;54(4):597\u2013613.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3662_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nmd.2022.12.001","volume":"33","author":"A Meyer","year":"2023","unstructured":"Meyer A, Troyanov Y, Korathanakhun P, Landon-Cardinal O, Leclair V, Allard-Chamard H, et al. Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis. Neuromuscul Disord. 2023;33(2):169\u201382.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"3662_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011;65(1):25\u201334.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"3662_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-017-3598-5","volume":"36","author":"JT Cox","year":"2017","unstructured":"Cox JT, Gullotti DM, Mecoli CA, Lahouti AH, Albayda J, Paik J, et al. \u201cHiker\u2019s feet\u201d: a novel cutaneous finding in the inflammatory myopathies. Clin Rheumatol. 2017;36(7):1683\u20136.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3662_CR14","first-page":"367","volume":"42","author":"J Torres-Ruiz","year":"2024","unstructured":"Torres-Ruiz J, Pinal-Fernandez I, Selva-O\u2019Callaghan A, Campbell B, Munoz-Braceras S, Mejia-Dominguez NR, et al. Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2024;42(2):367\u201376.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3662_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/rheumatology\/keab518","volume":"61","author":"Y Ichimura","year":"2022","unstructured":"Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, et al. Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash. Rheumatology (Oxford). 2022;61(3):1222\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3662_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/bpa.12844","volume":"30","author":"M Duchesne","year":"2020","unstructured":"Duchesne M, Leonard-Louis S, Landon-Cardinal O, Anquetil C, Mariampillai K, Monzani Q, et al. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis. Brain Pathol. 2020;30(5):867\u201376.","journal-title":"Brain Pathol"},{"key":"3662_CR17","doi-asserted-by":"crossref","unstructured":"Landon-Cardinal O, Baril-Dionne A, Hoa S, Meyer A, Leclair V, Bourre-Tessier J, Mansour AM, Zarka F, Makhzoum JP, Nehme J, et al. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies. RMD Open. 2020;6(2):e001357.","DOI":"10.1136\/rmdopen-2020-001357"},{"issue":"24","key":"3662_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MD.0000000000000223","volume":"93","author":"JL Senecal","year":"2014","unstructured":"Senecal JL, Isabelle C, Fritzler MJ, Targoff IN, Goldstein R, Gagne M, et al. An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome. Medicine (Baltimore). 2014;93(24):383\u201394.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"3662_CR19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/rheumatology\/kez406","volume":"59","author":"Z Betteridge","year":"2020","unstructured":"Betteridge Z, Chinoy H, Vencovsky J, Winer J, Putchakayala K, Ho P, et al. Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis. Rheumatology (Oxford). 2020;59(5):1026\u201330.","journal-title":"Rheumatology (Oxford)"},{"key":"3662_CR20","doi-asserted-by":"crossref","unstructured":"Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, Garcia de la Torre I, Herold M, Klotz W, Cruvinel WM, et al. Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Ann Rheum Dis. 2019;78(7):879\u2013889.","DOI":"10.1136\/annrheumdis-2018-214436"},{"issue":"4","key":"3662_CR21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/rheumatology\/kex458","volume":"57","author":"JD Pauling","year":"2018","unstructured":"Pauling JD, Salazar G, Lu H, Betteridge ZE, Assassi S, Mayes MD, et al. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1\/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis. Rheumatology (Oxford). 2018;57(4):712\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3662_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1272\/jnms.84.56","volume":"84","author":"M Kuwana","year":"2017","unstructured":"Kuwana M. Circulating anti-nuclear antibodies in systemic sclerosis: utility in diagnosis and disease subsetting. J Nippon Med Sch. 2017;84(2):56\u201363.","journal-title":"J Nippon Med Sch"},{"issue":"7","key":"3662_CR23","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/rheumatology\/key451","volume":"58","author":"M Infantino","year":"2019","unstructured":"Infantino M, Tampoia M, Fabris M, Alessio MG, Previtali G, Pesce G, et al. Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis. Rheumatology (Oxford). 2019;58(7):1239\u201344.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"3662_CR24","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis. 2009;68(10):1621\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3662_CR25","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1093\/rheumatology\/kead154","volume":"62","author":"J Demortier","year":"2023","unstructured":"Demortier J, Vautier M, Chosidow O, Gallay L, Bessis D, Berezne A, et al. Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature. Rheumatology (Oxford). 2023;62(12):3932\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3662_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol. 2017;52(1):1\u201319.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3662_CR27","doi-asserted-by":"crossref","unstructured":"Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O'Hanlon TP, Miller FW, Rider LG, Childhood Myositis Heterogeneity Study G, International Myositis Collaborative Study G. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54(11):3682-3689.","DOI":"10.1002\/art.22164"},{"issue":"2","key":"3662_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12016-021-08920-y","volume":"63","author":"M Fredi","year":"2022","unstructured":"Fredi M, Cavazzana I, Ceribelli A, Cavagna L, Barsotti S, Bartoloni E, et al. An Italian multicenter study on anti-NXP2 antibodies: clinical and serological associations. Clin Rev Allergy Immunol. 2022;63(2):240\u201350.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"3662_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"AW Friedman","year":"1996","unstructured":"Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 1996;26(1):459\u201367.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"3662_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3899\/jrheum.160618","volume":"44","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal R, Dhillon N, Fertig N, Koontz D, Qi Z, Oddis CV. A negative antinuclear antibody does not indicate autoantibody negativity in myositis: role of anticytoplasmic antibody as a screening test for antisynthetase syndrome. J Rheumatol. 2017;44(2):223\u20139.","journal-title":"J Rheumatol"},{"issue":"8","key":"3662_CR31","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","volume":"59","author":"SL Tansley","year":"2020","unstructured":"Tansley SL, Li D, Betteridge ZE, McHugh NJ. The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity. Rheumatology (Oxford). 2020;59(8):2109\u201314.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3662_CR32","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/rheumatology\/keae245","volume":"63","author":"K Yoshida","year":"2024","unstructured":"Yoshida K, Takahashi S, Kawai R, Saito T, Hatachi S, Shintani A, et al. Combination of cytoplasmic and nuclear patterns on Hep-2 antinuclear antibody is useful as a screening test for anti-synthetase syndrome. Rheumatology (Oxford). 2024;63(9):2590\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3662_CR33","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C, et al. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther. 2014;16(4):R138.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3662_CR34","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar4468","volume":"16","author":"L Drouot","year":"2014","unstructured":"Drouot L, Allenbach Y, Jouen F, Charuel JL, Martinet J, Meyer A, et al. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. Arthritis Res Ther. 2014;16(1):R39.","journal-title":"Arthritis Res Ther"},{"key":"3662_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/405956","volume":"2014","author":"L Musset","year":"2014","unstructured":"Musset L, Miyara M, Benveniste O, Charuel JL, Shikhman A, Boyer O, et al. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies. J Immunol Res. 2014;2014:405956.","journal-title":"J Immunol Res"},{"issue":"4","key":"3662_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.160871","volume":"44","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Betteridge ZE, Simou S, Jacques TS, Pilkington C, Wood M, et al. Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients. J Rheumatol. 2017;44(4):488\u201392.","journal-title":"J Rheumatol"},{"key":"3662_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.928861","volume":"13","author":"S Zhou","year":"2022","unstructured":"Zhou S, Lai J, Wu C, Liu Y, Liu Y, Zhao J, et al. Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis\/clinically amyopathic dermatomyositis: a retrospective study. Front Immunol. 2022;13:928861.","journal-title":"Front Immunol"},{"issue":"26","key":"3662_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000798","volume":"94","author":"C Dieval","year":"2015","unstructured":"Dieval C, Deligny C, Meyer A, Cluzel P, Champtiaux N, Lefevre G, et al. Myocarditis in patients with antisynthetase syndrome: prevalence, presentation, and outcomes. Medicine (Baltimore). 2015;94(26):e798.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3662_CR39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/23971983221090857","volume":"7","author":"A Yoshida","year":"2022","unstructured":"Yoshida A, Gono T, Okazaki Y, Shirai Y, Takeno M, Kuwana M. Severe digital ischemia as an unrecognized manifestation in patients with antisynthetase autoantibodies: case series and systematic literature review. J Scleroderma Relat Disord. 2022;7(3):204\u201316.","journal-title":"J Scleroderma Relat Disord"},{"issue":"9","key":"3662_CR40","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/art.42150","volume":"74","author":"H So","year":"2022","unstructured":"So H, So J, Lam TT, Wong VT, Ho R, Li WL, et al. Performance of the 2017 European Alliance of Associations for Rheumatology\/American College of Rheumatology classification criteria in patients with idiopathic inflammatory myopathy and anti-melanoma differentiation-associated protein 5 positivity. Arthritis Rheumatol. 2022;74(9):1588\u201392.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3662_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W, Benveniste O, Group EtWS. 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 december 2018. Neuromuscul Disord. 2020;30(1):70\u201392.","journal-title":"Neuromuscul Disord"},{"key":"3662_CR42","doi-asserted-by":"crossref","unstructured":"Stenzel W, Mammen AL, Gallay L, Holzer MT, Kleefeld F, Benveniste O, Allenbach Y, Group EASS: 273rd ENMC International workshop: clinico-Sero-morphological classification of the Antisynthetase syndrome. Amsterdam, The Netherlands, 27\u201329 October 2023. Neuromuscul Disord. 2024;45:104453.","DOI":"10.1016\/j.nmd.2024.104453"},{"issue":"6","key":"3662_CR43","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","volume":"60","author":"AGS Oldroyd","year":"2021","unstructured":"Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, et al. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2021;60(6):2615\u201328.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3662_CR44","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ard.2025.01.050","volume":"84","author":"G Zanframundo","year":"2025","unstructured":"Zanframundo G, Dourado E, Bauer-Ventura I, Faghihi-Kashani S, Yoshida A, Loganathan A, et al. The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project. Ann Rheum Dis. 2025;84(7):1207\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3662_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103420","volume":"22","author":"J Thuner","year":"2023","unstructured":"Thuner J, Coutant F. IFN-gamma: an overlooked cytokine in dermatomyositis with anti-MDA5 antibodies. Autoimmun Rev. 2023;22(10):103420.","journal-title":"Autoimmun Rev"},{"key":"3662_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40478-014-0154-2","volume":"2","author":"J Aouizerate","year":"2014","unstructured":"Aouizerate J, De Antonio M, Bassez G, Gherardi RK, Berenbaum F, Guillevin L, et al. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol Commun. 2014;2:154.","journal-title":"Acta Neuropathol Commun"},{"key":"3662_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X251353297","volume":"13","author":"T Cotton","year":"2025","unstructured":"Cotton T, Hudson M, Troyanov Y, Leclair V, Gyger G. Nailfold capillaroscopy in myositis: a case series. SAGE Open Med Case Rep. 2025;13:2050313X251353297.","journal-title":"SAGE Open Med Case Rep"},{"issue":"7","key":"3662_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12840","volume":"48","author":"B Ellezam","year":"2022","unstructured":"Ellezam B, Leclair V, Troyanov Y, Bersali I, Giannini M, Hoa S, et al. Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis. Neuropathol Appl Neurobiol. 2022;48(7):e12840.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"3662_CR49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-021-02335-x","volume":"142","author":"B Ellezam","year":"2021","unstructured":"Ellezam B, Leclair V, Troyanov Y, Meyer A, Hudson M, Landon-Cardinal O. Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of \u201cscleromyositis.\u201d Acta Neuropathol. 2021;142(2):395\u20137.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3662_CR50","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00401-021-02305-3","volume":"141","author":"E Siegert","year":"2021","unstructured":"Siegert E, Uruha A, Goebel HH, Preusse C, Casteleyn V, Kleefeld F, et al. Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology. Acta Neuropathol. 2021;141(6):917\u201327.","journal-title":"Acta Neuropathol"},{"issue":"13","key":"3662_CR51","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0000000000001422","volume":"84","author":"W Stenzel","year":"2015","unstructured":"Stenzel W, Preusse C, Allenbach Y, Pehl D, Junckerstorff R, Heppner FL, et al. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy. Neurology. 2015;84(13):1346\u201354.","journal-title":"Neurology"},{"issue":"4","key":"3662_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/01913120802209379","volume":"32","author":"IM Bronner","year":"2008","unstructured":"Bronner IM, Hoogendijk JE, Veldman H, Ramkema M, van den Bergh Weerman MA, Rozemuller AJ, et al. Tubuloreticular structures in different types of myositis: implications for pathogenesis. Ultrastruct Pathol. 2008;32(4):123\u20136.","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"3662_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13155","volume":"33","author":"J Tanboon","year":"2023","unstructured":"Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S, et al. Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathol. 2023;33(4):e13155.","journal-title":"Brain Pathol"},{"issue":"5","key":"3662_CR54","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/nan.12519","volume":"45","author":"A Uruha","year":"2019","unstructured":"Uruha A, Allenbach Y, Charuel JL, Musset L, Aussy A, Boyer O, et al. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis. Neuropathol Appl Neurobiol. 2019;45(5):513\u201322.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"3662_CR55","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","volume":"98","author":"J Tanboon","year":"2022","unstructured":"Tanboon J, Inoue M, Saito Y, Tachimori H, Hayashi S, Noguchi S, et al. Dermatomyositis: muscle pathology according to antibody subtypes. Neurology. 2022;98(7):e739\u201349.","journal-title":"Neurology"},{"issue":"5","key":"3662_CR56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/nan.12551","volume":"45","author":"M Inoue","year":"2019","unstructured":"Inoue M, Tanboon J, Okubo M, Theerawat K, Saito Y, Ogasawara M, et al. Absence of sarcoplasmic myxovirus resistance protein A (MxA) expression in antisynthetase syndrome in a cohort of 194 cases. Neuropathol Appl Neurobiol. 2019;45(5):523\u20134.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"3662_CR57","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/mus.28066","volume":"69","author":"C Xing","year":"2024","unstructured":"Xing C, Trivedi J, Bitencourt N, Burns DK, Reisch JS, Cai C. Myxovirus resistance protein A (MxA) expression in myositides: sarcoplasmic expression is common in both dermatomyositis and lupus myositis. Muscle Nerve. 2024;69(5):548\u201355.","journal-title":"Muscle Nerve"},{"issue":"1","key":"3662_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000811","volume":"5","author":"M Rigolet","year":"2019","unstructured":"Rigolet M, Hou C, Baba Amer Y, Aouizerate J, Periou B, Gherardi RK, et al. Distinct interferon signatures stratify inflammatory and dysimmune myopathies. RMD Open. 2019;5(1):e000811.","journal-title":"RMD Open"},{"key":"3662_CR59","doi-asserted-by":"crossref","unstructured":"Lessard LER, Robert M, Fenouil T, Mounier R, Landel V, Carlesimo M, et al. Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: a histopathological cohort study. J Neuropathol Exp Neurol. 2024;83(12):1060\u201375.","DOI":"10.1093\/jnen\/nlae098"},{"issue":"1","key":"3662_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nmd.2018.11.004","volume":"29","author":"Y Hou","year":"2019","unstructured":"Hou Y, Liu M, Luo YB, Sun Y, Shao K, Dai T, et al. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort. Neuromuscul Disord. 2019;29(1):5\u201313.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"3662_CR61","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000535","volume":"6","author":"N Uchio","year":"2019","unstructured":"Uchio N, Taira K, Ikenaga C, Kadoya M, Unuma A, Yoshida K, et al. Inflammatory myopathy with myasthenia gravis: thymoma association and polymyositis pathology. Neurol Neuroimmunol Neuroinflamm. 2019;6(2):e535.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3662_CR62","doi-asserted-by":"crossref","unstructured":"Astouati Q, Machet T, Houssais C, Noury JB, Allenbach Y, Gallay L, Quere B, Assan F, Benveniste O, Broner J, et al. Inclusion-body myositis associated with Sjogren's disease: clinical characteristics and comparison with other Sjogren-associated myositis. Rheumatology (Oxford). 2024;64(3):1431\u201336.","DOI":"10.1093\/rheumatology\/keae129"},{"issue":"3","key":"3662_CR63","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mus.25507","volume":"56","author":"M Casal-Dominguez","year":"2017","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Mego M, Accarino A, Jubany L, Azpiroz F, et al. High-resolution manometry in patients with idiopathic inflammatory myopathy: elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset. Muscle Nerve. 2017;56(3):386\u201392.","journal-title":"Muscle Nerve"},{"issue":"5","key":"3662_CR64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14(5):337\u201345.","journal-title":"Neuromuscul Disord"},{"key":"3662_CR65","doi-asserted-by":"crossref","unstructured":"De Bleecker JL, Lundberg IE, de Visser M. Group EMMBS: 193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands. Neuromuscul Disord. 2013;23(11):945\u201351.","DOI":"10.1016\/j.nmd.2013.07.007"},{"issue":"3","key":"3662_CR66","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","volume":"25","author":"JL De Bleecker","year":"2015","unstructured":"De Bleecker JL, De Paepe B, Aronica E, de Visser M, Group EMMBS, Amato A, et al. 205th ENMC international workshop: pathology diagnosis of idiopathic inflammatory myopathies part II 28\u201330 march 2014, Naarden, the Netherlands. Neuromuscul Disord. 2015;25(3):268\u201372.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"3662_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W. Immune-Mediated Necrotizing Myopathies Working G: 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord. 2018;28(1):87\u201399.","journal-title":"Neuromuscul Disord"},{"key":"3662_CR68","doi-asserted-by":"crossref","unstructured":"Lilleker JB, Naddaf E, Saris CGJ, Schmidt J, de Visser M, Weihl CC, nd Ewp: 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16\u201318. Hoofddorp, The Netherlands. Neuromuscul Disord. 2023;2024(37):36\u201351.","DOI":"10.1016\/j.nmd.2024.03.001"},{"issue":"3","key":"3662_CR69","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/rheumatology\/keaa443","volume":"60","author":"M Giannini","year":"2021","unstructured":"Giannini M, Fiorella ML, Tampoia M, Girolamo F, Fornaro M, Amati A, et al. Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis. Rheumatology (Oxford). 2021;60(3):1234\u201342.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"3662_CR70","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/acr.20325","volume":"62","author":"I Marie","year":"2010","unstructured":"Marie I, Menard JF, Hatron PY, Hachulla E, Mouthon L, Tiev K, et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010;62(12):1748\u201355.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3662_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nmd.2020.11.001","volume":"31","author":"Z Argov","year":"2021","unstructured":"Argov Z, de Visser M. Dysphagia in adult myopathies. Neuromuscul Disord. 2021;31(1):5\u201320.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"3662_CR72","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1212\/WNL.0000000000011350","volume":"96","author":"T Warnecke","year":"2021","unstructured":"Warnecke T, Labeit B, Schroeder J, Reckels A, Ahring S, Lapa S, et al. Neurogenic dysphagia: systematic review and proposal of a classification system. Neurology. 2021;96(6):e876\u201389.","journal-title":"Neurology"},{"issue":"8","key":"3662_CR73","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jamda.2021.09.026","volume":"23","author":"B Labeit","year":"2022","unstructured":"Labeit B, Ahring S, Boehmer M, Sporns P, Sauer S, Claus I, et al. Comparison of simultaneous swallowing endoscopy and videofluoroscopy in neurogenic dysphagia. J Am Med Dir Assoc. 2022;23(8):1360\u20136.","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"3662_CR74","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.nmd.2023.08.014","volume":"33","author":"M de Visser","year":"2023","unstructured":"de Visser M, Carlier P, Vencovsky J, Kubinova K, Preusse C, group EMIiIIMws. 255th ENMC workshop: muscle imaging in idiopathic inflammatory myopathies. 15th january, 16th january and 22nd january 2021 - virtual meeting and hybrid meeting on 9th and 19th september 2022 in Hoofddorp, The Netherlands. Neuromuscul Disord. 2023;33(10):800\u201316.","journal-title":"Neuromuscul Disord"},{"key":"3662_CR75","doi-asserted-by":"crossref","unstructured":"Pijnenburg L, Giannini M, Bouchard-Marmen M, Arnaud L, Barsotti S, Bellando-Randone S, Bernardi L, Bini P, Blagojevic J, Codullo V, et al. In inflammatory myopathies, dropped head\/bent spine syndrome is associated with scleromyositis: an international case-control study. RMD Open. 2023;9(3):e003081.","DOI":"10.1136\/rmdopen-2023-003081corr1"},{"issue":"5","key":"3662_CR76","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.21822","volume":"54","author":"A Pestronk","year":"2006","unstructured":"Pestronk A, Kos K, Lopate G, Al-Lozi MT. Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features. Arthritis Rheum. 2006;54(5):1687\u201396.","journal-title":"Arthritis Rheum"},{"key":"3662_CR77","doi-asserted-by":"crossref","unstructured":"Suarez-Calvet X, Alonso-Perez J, Castellvi I, Carrasco-Rozas A, Fernandez-Simon E, Zamora C, Martinez-Martinez L, Alonso-Jimenez A, Rojas-Garcia R, Turon J, et al. Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis. Neurol Neuroimmunol Neuroinflamm. 2020;7(3):e694.","DOI":"10.1212\/NXI.0000000000000694"},{"issue":"2","key":"3662_CR78","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4081\/reumatismo.2021.1397","volume":"73","author":"CSR Araujo","year":"2021","unstructured":"Araujo CSR, Miossi R, De Souza FHC, Costa MD, Da Silva AMS, Campos ED, et al. Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature. Reumatismo. 2021;73(2):122\u201330.","journal-title":"Reumatismo"},{"key":"3662_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152529","volume":"68","author":"F Espinosa-Ortega","year":"2024","unstructured":"Espinosa-Ortega F, Lodin K, Dastmalchi M, Vencovsky J, Diederichsen LP, Shinjo SK, et al. Autoantibodies and damage in patients with idiopathic inflammatory myopathies: a longitudinal multicenter study from the MYONET international network. Semin Arthritis Rheum. 2024;68:152529.","journal-title":"Semin Arthritis Rheum"},{"key":"3662_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152408","volume":"65","author":"V Leclair","year":"2024","unstructured":"Leclair V, Notarnicola A, Krystufkova O, Mann H, Andersson H, Diederichsen LP, et al. Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies. Semin Arthritis Rheum. 2024;65:152408.","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"3662_CR81","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/art.40895","volume":"71","author":"A Aussy","year":"2019","unstructured":"Aussy A, Freret M, Gallay L, Bessis D, Vincent T, Jullien D, et al. The IgG2 isotype of anti-transcription intermediary factor 1gamma autoantibodies is a biomarker of cancer and mortality in adult dermatomyositis. Arthritis Rheumatol. 2019;71(8):1360\u201370.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"3662_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154746","volume":"11","author":"N Mugii","year":"2016","unstructured":"Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Oohata S, Okita H, et al. Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS ONE. 2016;11(5):e0154746.","journal-title":"PLoS ONE"},{"issue":"10","key":"3662_CR83","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1093\/rheumatology\/keaa112","volume":"59","author":"M Kanaoka","year":"2020","unstructured":"Kanaoka M, Yamaguchi Y, Watanabe T, Akita A, Ototake Y, Ikeda N, et al. Clinically amyopathic dermatomyositis with anti-transcriptional intermediary factor 1-gamma autoantibody positivity. Rheumatology (Oxford). 2020;59(10):e68\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3662_CR84","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","volume":"57","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Ferrer-Fabregas B, Trallero-Araguas E, Balada E, Martinez MA, Milisenda JC, et al. Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. Rheumatology (Oxford). 2018;57(2):388\u201396.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"3662_CR85","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1093\/rheumatology\/keab260","volume":"60","author":"N Cordel","year":"2021","unstructured":"Cordel N, Derambure C, Coutant S, Mariette X, Jullien D, Debarbieux S, et al. TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1gamma positive cancer-associated dermatomyositis. Rheumatology (Oxford). 2021;60(12):5863\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3662_CR86","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/art.42474","volume":"75","author":"D Fiorentino","year":"2023","unstructured":"Fiorentino D, Mecoli CA, Igusa T, Albayda J, Paik JJ, Tiniakou E, et al. Association of anti-CCAR1 autoantibodies with decreased cancer risk relative to the general population in patients with anti-transcriptional intermediary factor 1gamma-positive dermatomyositis. Arthritis Rheumatol. 2023;75(7):1238\u201345.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3662_CR87","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/ard-2022-222441","volume":"82","author":"Y Hosono","year":"2023","unstructured":"Hosono Y, Sie B, Pinal-Fernandez I, Pak K, Mecoli CA, Casal-Dominguez M, et al. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1gamma autoantibodies. Ann Rheum Dis. 2023;82(2):246\u201352.","journal-title":"Ann Rheum Dis"},{"key":"3662_CR88","doi-asserted-by":"crossref","unstructured":"Fiorentino DF, Mecoli CA, Rosen MC, Chung LS, Christopher-Stine L, Rosen A, et al. Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence. J Clin Invest. 2022;132(2):e150201.","DOI":"10.1172\/JCI150201"},{"issue":"3","key":"3662_CR89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","volume":"87","author":"A Hida","year":"2016","unstructured":"Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M, et al. Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study. Neurology. 2016;87(3):299\u2013308.","journal-title":"Neurology"},{"issue":"12","key":"3662_CR90","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/NEN.0000000000000132","volume":"73","author":"C Cai","year":"2014","unstructured":"Cai C, Alshehri A, Choksi R, Pestronk A. Regional ischemic immune myopathy: a paraneoplastic dermatomyopathy. J Neuropathol Exp Neurol. 2014;73(12):1126\u201333.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"3662_CR91","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/1346-8138.15284","volume":"47","author":"N Ikeda","year":"2020","unstructured":"Ikeda N, Yamaguchi Y, Kanaoka M, Ototake Y, Akita A, Watanabe T, et al. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-gamma antibody in patients with dermatomyositis. J Dermatol. 2020;47(5):490\u20136.","journal-title":"J Dermatol"},{"key":"3662_CR92","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/B978-0-12-823912-4.00022-0","volume":"200","author":"AL Mammen","year":"2024","unstructured":"Mammen AL. Paraneoplastic myopathies. Handb Clin Neurol. 2024;200:327\u201332.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"3662_CR93","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40674-022-00197-2","volume":"8","author":"A Selva-O'Callaghan","year":"2022","unstructured":"Selva-O\u2019Callaghan A, Trallero-Araguas E, Ros J, Gil-Vila A, Lostes J, Agusti A, et al. Management of cancer-associated myositis. Curr Treatm Opt Rheumatol. 2022;8(4):91\u2013104.","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"4","key":"3662_CR94","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/art.42311","volume":"75","author":"CA Mecoli","year":"2023","unstructured":"Mecoli CA, Igusa T, Chen M, Wang X, Albayda J, Paik JJ, et al. Subsets of idiopathic inflammatory myositis enriched for contemporaneous cancer relative to the general population. Arthritis Rheumatol. 2023;75(4):620\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"3662_CR95","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino DF, Chung LS, Christopher-Stine L, Zaba L, Li S, Mammen AL, et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma. Arthritis Rheum. 2013;65(11):2954\u201362.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3662_CR96","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1093\/rheumatology\/keac288","volume":"61","author":"S Selickaja","year":"2022","unstructured":"Selickaja S, Galindo-Feria AS, Dani L, Mimori T, Ronnelid J, Holmqvist M, et al. ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis. Rheumatology (Oxford). 2022;61(12):4991\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3662_CR97","first-page":"1048","volume":"37","author":"DF Fiorentino","year":"2019","unstructured":"Fiorentino DF, Gutierrez-Alamillo L, Hines D, Yang Q, Casciola-Rosen L. Distinct dermatomyositis populations are detected with different autoantibody assay platforms. Clin Exp Rheumatol. 2019;37(6):1048\u201351.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"3662_CR98","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/1346-8138.16295","volume":"49","author":"Y Ichimura","year":"2022","unstructured":"Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, et al. Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties. J Dermatol. 2022;49(4):441\u20137.","journal-title":"J Dermatol"},{"issue":"8","key":"3662_CR99","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3899\/jrheum.141443","volume":"42","author":"I Pinal-Fernandez","year":"2015","unstructured":"Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL. The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis. J Rheumatol. 2015;42(8):1448\u201354.","journal-title":"J Rheumatol"},{"key":"3662_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2025.105363","volume":"50","author":"MP Skolka","year":"2025","unstructured":"Skolka MP, Pinal-Fernandez I, Mammen AL, Liewluck T. Emerging atypical clinicopathological manifestations of immune-mediated necrotizing myopathy (IMNM). Neuromuscul Disord. 2025;50:105363.","journal-title":"Neuromuscul Disord"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03662-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03662-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:03:18Z","timestamp":1763028198000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03662-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3662"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03662-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research ethics board (REB) at CHUM (reference number 2015\u20135607-CE14.238) and HSCM (reference number 2014\u20131042). Individual patient consent was not required by REB, as no personal identifying information was required or reported for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"All authors have given consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}